Anticancer Research: 42 (8)

August 2022; Volume 42,Issue 8

Review

You have access
Radiotherapy in Metastatic Urothelial Carcinoma: Rationale and Clinical Applications
VASSILIOS VASSILIOU, THEODORA KATSILA, SAMANTHA C. SODERGREN and DIMITRIOS KARDAMAKIS

Anticancer Research August 2022, 42 (8) 3767-3778; DOI: https://doi.org/10.21873/anticanres.15867

Experimental Studies

Open Access
Tropomyosin-related Kinase B Is Potentially a Biomarker of Prognosis and Therapeutic Target for Malignant Thymic Epithelial Tumors
KEIGO OZONO, HIDEYA ONISHI, NAOYA IWAMOTO, KATSUYA NAKAMURA, KEI MIYOSHI, MASAFUMI NAKAMURA and YOSHINAO ODA

Anticancer Research August 2022, 42 (8) 3779-3787; DOI: https://doi.org/10.21873/anticanres.15868
You have access
Eriodictyol Attenuates Cholangiocarcinoma Malignancy by Regulating HMOX1 Expression: An In Vitro Study
JUNGWHOI LEE, WOOGWANG SIM, SONG-I HAN, JI-HUN BYEON, SOO-BEOM JIN, NUR AZIZAH ARRYANIE BINTI MORSHIDI, YE-YOUNG HONG, YUBIN JUNG and JAE HOON KIM

Anticancer Research August 2022, 42 (8) 3789-3798; DOI: https://doi.org/10.21873/anticanres.15869
Open Access
The Contribution of Interleukin-8 Rs4073 Genotypes to Triple Negative Breast Cancer Risk in Taiwan
YUN-CHI WANG, ZHI-HONG WANG, JUNG-HSING YEN, YI-CHENG SHEN, TE-CHUN SHEN, WEN-SHIN CHANG, CHEN-HSIEN SU, KAI-YUAN CHEN, CHUN-MING YEN, HSU-TUNG LEE, JAI-SING YANG, DA-TIAN BAU and CHIA-WEN TSAI

Anticancer Research August 2022, 42 (8) 3799-3806; DOI: https://doi.org/10.21873/anticanres.15870
You have access
STAT3 Inactivation and Induction of Apoptosis Associate With Fluoxetine-inhibited Epithelial-mesenchymal Transition and Growth of Triple-negative Breast Cancer In Vivo
PEN-AN LIAO, PEI-YI CHU, ZHAO-LIN TAN, FEI-TING HSU, YANG-CHENG LEE and HSING-JU WU

Anticancer Research August 2022, 42 (8) 3807-3814; DOI: https://doi.org/10.21873/anticanres.15871
You have access
The Expression of SIRT6 Is Associated With Treatment Outcome in Elder Patients With Oral Cancer
HARUKA YOSHII, KAZUMASA SEKIHARA, YUKA IDETA, SHINTARO NAKAJIMA, IKUMA KATO, MAKIKO OKUBO-SATO, KEI SUGIURA, KENJI MITSUDO and MITOMU KIOI

Anticancer Research August 2022, 42 (8) 3815-3823; DOI: https://doi.org/10.21873/anticanres.15872
You have access
Magnolol Induces Apoptosis Through Extrinsic/intrinsic Pathways and Attenuates NF-κB/STAT3 Signaling in Non-small-cell Lung Cancer Cells
YANG-CHENG LEE, YUEH-SHAN WENG, HSIAO-YU WANG, FEI-TING HSU, FU-SHIN CHUEH, JENG-YUAN WU, WEI-LUNG CHEN and JIANN-HWA CHEN

Anticancer Research August 2022, 42 (8) 3825-3833; DOI: https://doi.org/10.21873/anticanres.15873
You have access
Extracellular Vesicles from EGFR T790M/L858R-mutant Non-small Cell Lung Cancer Promote Cancer Progression
KEATDAMRONG JANPIPATKUL, WITTAYA PANVONGSA, WITTAWIN WORAKITCHANON, THANYANAN REUNGWETWATTANA and ARTHIT CHAIROUNGDUA

Anticancer Research August 2022, 42 (8) 3835-3844; DOI: https://doi.org/10.21873/anticanres.15874

Clinical Studies

Open Access
A Reappraisal of Definitive Chemoradiotherapy for Older Adults With Advanced Head and Neck Cancer
TIMOTHY D. SMILE, CHANDANA A. REDDY, BRIAN MATIA, CHRISTOPHER W. FLEMING, CHAIM DOMB, JESSICA L. GEIGER, NIKHIL P. JOSHI, NEIL M. WOODY, DEBORAH J. CHUTE, CHRISTOPHER C. GRIFFITH, DAVID J. ADELSTEIN and SHLOMO A. KOYFMAN

Anticancer Research August 2022, 42 (8) 3845-3852; DOI: https://doi.org/10.21873/anticanres.15875
Open Access
Intrathecal Chemotherapy as a Potential Treatment for Steroid-refractory Immune Effector Cell-associated Neurotoxicity Syndrome
PALASH ASAWA, URWAT VUSQA, CYRUS KHAN, YAZAN SAMHOURI and SALMAN FAZAL

Anticancer Research August 2022, 42 (8) 3853-3856; DOI: https://doi.org/10.21873/anticanres.15876
Open Access
Long-term Stable Disease in a Rectal-cancer Patient Treated by Methionine Restriction With Oral Recombinant Methioninase and a Low-methionine Diet
YUTARO KUBOTA, QINGHONG HAN, KAZUYUKI HAMADA, YUSUKE AOKI, NORIYUKI MASAKI, KOYA OBARA, TAKUYA TSUNODA and ROBERT M. HOFFMAN

Anticancer Research August 2022, 42 (8) 3857-3861; DOI: https://doi.org/10.21873/anticanres.15877
You have access
Metronomic Cyclophosphamide With Cisplatin and Bevacizumab for Refractory Anaplastic Ependymoma: A Retrospective Study
XAVIER CHODERLOS DE LACLOS, DIDIER FRAPPAZ, GUIDO AHLE, CHARLOTTE BRONNIMANN, ISABELLE CATRY-THOMAS, ANTHONY JONCOUR, FRANCOIS GHIRINGHELLI and ELODIE VAULEON

Anticancer Research August 2022, 42 (8) 3863-3867; DOI: https://doi.org/10.21873/anticanres.15878
You have access
Outcome of Scapular Ewing Sarcoma
JOHN B. HARGISS, JOSHUA R. LABOTT, SAMUEL E. BROIDA, PETER S. ROSE, JOHNATHAN D. BARLOW and MATTHEW T. HOUDEK

Anticancer Research August 2022, 42 (8) 3869-3872; DOI: https://doi.org/10.21873/anticanres.15879
You have access
Clinical Significance of EREG Gene Expression in Gastric Cancer Tissue After Curative Surgery
HIDEAKI SUEMATSU, ITARU HASHIMOTO, YUKIHIKO HIROSHIMA, HAYATO WATANABE, KAZUKI KANO, KOSUKE TAKAHASHI, TORU AOYAMA, TAKANOBU YAMADA, HIROSHI TAMAGAWA, TAKASHI OGATA, NORIO YUKAWA, YASUSHI RINO, MUNETAKA MASUDA, YOHEI MIYAGI and TAKASHI OSHIMA

Anticancer Research August 2022, 42 (8) 3873-3878; DOI: https://doi.org/10.21873/anticanres.15880
You have access
Neoadjuvant Treatment as a Risk Factor for Variation of Upper Limb Lymph Node Drainage During Axillary Reverse Mapping in Breast Cancer: A Prospective Observational Study
GIANLUCA VANNI, MARCO PELLICCIARO, MARCO MATERAZZO, OMBRETTA MELAIU, BENEDETTO LONGO, VALERIO CERVELLI and ORESTE CLAUDIO BUONOMO

Anticancer Research August 2022, 42 (8) 3879-3888; DOI: https://doi.org/10.21873/anticanres.15881
You have access
Comparison Between FOLFIRINOX and nal-IRI/FL as Second-line Treatment After Gemcitabine Plus Nab-paclitaxel for Pancreatic Cancer
TOMOHISA OTSU, YOSHIKUNI INOKAWA, HIDEKI TAKAMI, MASAMICHI HAYASHI, KEISUKE KURIMOTO, NOBUTAKE TANAKA, HARUYOSHI TANAKA, DAI SHIMIZU, NORIFUMI HATTORI, MITSURO KANDA, CHIE TANAKA, GORO NAKAYAMA and YASUHIRO KODERA

Anticancer Research August 2022, 42 (8) 3889-3894; DOI: https://doi.org/10.21873/anticanres.15882
You have access
MR Prediction of Malignant Switch With the Cyst Fluid’s T2 Value in Intraductal Papillary Mucinous Neoplasm of the Pancreas: A Preliminary Study
SEIICHIRO TAKAO, AKIHIRO NISHIE, YASUHIRO USHIJIMA, YUKIHISA TAKAYAMA, KOICHIRO MORITA, KEISUKE ISHIMATSU, YUTAKA KOGA, YASUHISA MORI, YUTA AKAMINE and KOUSEI ISHIGAMI

Anticancer Research August 2022, 42 (8) 3895-3903; DOI: https://doi.org/10.21873/anticanres.15883
You have access
Additional Effects of Docetaxel on Neoadjuvant Radiotherapy With Cisplatin/5-Fluorouracil for Esophageal Squamous Cell Carcinoma
KEN SASAKI, YUSUKE TSURUDA, MASATAKA SHIMONOSONO, MASAHIRO NODA, YASUTO UCHIKADO, TAKAAKI ARIGAMI, DAISUKE MATSUSHITA, SHINICHIRO MORI, AKIHIRO NAKAJO, HIROSHI KURAHARA and TAKAO OHTSUKA

Anticancer Research August 2022, 42 (8) 3905-3911; DOI: https://doi.org/10.21873/anticanres.15884
You have access
Everolimus for Treating Hormone Receptor-positive Metastatic Breast Cancer Previously Treated With Cyclin-dependent Kinase 4/6 Inhibitors
SAE KITANO, AKIKO HONDA, NAOKO ITOI and TECCHUU LEE

Anticancer Research August 2022, 42 (8) 3913-3919; DOI: https://doi.org/10.21873/anticanres.15885
You have access
Prognostic Role of Carcinoembryonic Antigen and Carbohydrate Antigen 19-9 in Stage IV Colorectal Cancer
HIDETAKA KAWAMURA, MICHITAKA HONDA, YOSHINAO TAKANO, SHUNJI KINUTA, TAKAHIRO KAMIGA, SHIGEHIRA SAJI and KOJI KONO

Anticancer Research August 2022, 42 (8) 3921-3928; DOI: https://doi.org/10.21873/anticanres.15886
You have access
The Albumin–Bilirubin Score Is a Prognostic Factor for Gastric Cancer Patients Who Receive Curative Treatment
MIWHA JU, TORU AOYAMA, KEISUKE KOMORI, HIROSHI TAMAGAWA, AYAKO TAMAGAWA, YUKIO MAEZAWA, JUNYA MORITA, ATSUSHI ONODERA, KAZUYA ENDO, ITARU HASHIMOTO, KAZUKI KANO, KENTARO HARA, HARUHIKO CHO, MASATO NAKAZONO, KENKI SEGAMI, TETSUSHI ISHIGURO, SHIZUNE ONUMA, TAKASHI OSHIMA, NORIO YUKAWA and YASUSHI RINO

Anticancer Research August 2022, 42 (8) 3929-3935; DOI: https://doi.org/10.21873/anticanres.15887
You have access
The Effect of Smoking on Endocrine Therapy for Stage IV Hormone Receptor Positive Breast Cancer
KOJI TAKADA, SHINICHIRO KASHIWAGI, RIKA KOUHASHI, NOZOMI IIMORI, AKIMICHI YABUMOTO, WATARU GOTO, YUKA ASANO, YUKIE TAUCHI, TAMAMI MORISAKI, MASATSUNE SHIBUTANI, HIROAKI TANAKA and MASAICHI OHIRA

Anticancer Research August 2022, 42 (8) 3937-3946; DOI: https://doi.org/10.21873/anticanres.15888
You have access
Effectiveness of Porous Glass Membrane Pumping Emulsification Device in Transarterial Chemoembolization for Solitary Hepatocellular Carcinoma
NORIHIRO IMAI, MASATOSHI ISHIGAMI, YUMI OIE, MOTOKI KUMAGAI, YOSUKE INUKAI, SHINYA YOKOYAMA, KENTA YAMAMOTO, TAKANORI ITO, YOJI ISHIZU, TAKASHI HONDA and HIROKI KAWASHIMA

Anticancer Research August 2022, 42 (8) 3947-3951; DOI: https://doi.org/10.21873/anticanres.15889
You have access
Clinical Outcome After Esophagectomy or Definitive Chemoradiotherapy in Elderly Patients (≥80 Years) With Esophageal Cancer
MASATAKA SHIMONOSONO, KEN SASAKI, YUSUKE TSURUDA, MASAHIRO NODA, YASUTO UCHIKADO, TAKAAKI ARIGAMI, DAISUKE MATSUSHITA, SHINICHIRO MORI, HIROSHI KURAHARA, AKIHIRO NAKAJO and TAKAO OHTSUKA

Anticancer Research August 2022, 42 (8) 3953-3961; DOI: https://doi.org/10.21873/anticanres.15890
You have access
Phase II Study of a Multi-center Randomized Controlled Trial to Evaluate Oral Vitamin B12 Treatment for Vitamin B12 Deficiency After Total Gastrectomy in Gastric Cancer Patients
TORU AOYAMA, YUKIO MAEZAWA, HARUHIKO CHO, YUSUKE SAIGUSA, JUN TAMURA, KAZUHITO TSUCHIDA, KEISUKE KOMORI, KAZUKI KANO, KENKI SEGAMI, KENTARO HARA, KOTARO SENUKI, YOSHIHIRO SUZUKI, MICHIYO YAMAKAWA, HIROSHI TAMAGAWA, TAKASHI OSHIMA, NORIO YUKAWA and YASUSHI RINO

Anticancer Research August 2022, 42 (8) 3963-3970; DOI: https://doi.org/10.21873/anticanres.15891
You have access
Metastatic SMARCB1 Deficient Skin Carcinoma With Neuroendocrine Differentiation in the Parotid Glands Clinically Mimicking Primary Salivary Gland Malignancy: Unusual Case With Diagnostic Pitfalls
FELIX FANG, QI ZHANG, JUAN M. PINTO-CUBEROS and JINPING LAI

Anticancer Research August 2022, 42 (8) 3971-3974; DOI: https://doi.org/10.21873/anticanres.15892
You have access
Primary Central Nervous System Post–transplant Lymphoproliferative Disorder Misdiagnosed as Glioblastoma: A Case Report
HAKU TANAKA, RYOSUKE MATSUDA, MITSUTOSHI NAKAMURA, ICHIRO NAKAGAWA and HIROYUKI NAKASE

Anticancer Research August 2022, 42 (8) 3975-3979; DOI: https://doi.org/10.21873/anticanres.15893

PROCEEDINGS OF THE 25TH ANNUAL MEETING OF THE SOCIETY OF BIOTHERAPEUTIC APPROACHES

Preface
- Open Access
  Proceedings of the 25th Annual Meeting of the Society of Biotherapeutic Approaches
  S. Miyamoto and G.-I. Soma
  
  Anticancer Research August 2022, 42 (8) 3981-3982;

Experimental Studies

Open Access
Anti-inflammatory and Insulin Signaling Phenotype Induced by Repeated Lipopolysaccharide Stimulation in 3T3-L1 Adipocytes
KAZUSHI YAMAMOTO, MASASHI YAMASHITA, HIROYUKI INAGAWA, CHIE KOHCHI and GEN-ICHIRO SOMA

Anticancer Research August 2022, 42 (8) 3983-3991; DOI: https://doi.org/10.21873/anticanres.15894
Open Access
Cancer Spheroid Proliferation Is Suppressed by a Novel Low-toxicity Compound, Pyra-Metho-Carnil, in a Context-independent Manner
KAZUMASA YOSHIDA, KENSUKE NISHI, SHUHEI ISHIKURA, KAZUHIKO NAKABAYASHI, RYO YAZAKI, TAKASHI OHSHIMA, MASAHIKO SUENAGA, SENJI SHIRASAWA and TOSHIYUKI TSUNODA

Anticancer Research August 2022, 42 (8) 3993-4001; DOI: https://doi.org/10.21873/anticanres.15895
You have access
Significance of Intraperitoneal-free KRT20 and CEACAM6 mRNA Expression for Peritoneal Recurrence of Gastric Cancer
HIDEAKI KAKU, KEISHIRO AOYAGI, TOMOYA SUDO, YUYA TANAKA, TAIZAN MINAMI, TARO ISOBE, JUNYA KIZAKI, YUKI UMETANI, NAOTAKA MURAKAMI, FUMIHIKO FUJITA and YOSHITO AKAGI

Anticancer Research August 2022, 42 (8) 4003-4010; DOI: https://doi.org/10.21873/anticanres.15896
You have access
Experimental Exploration for Genes Related to Susceptibility and Resistance to Irinotecan
SUGURU OGATA, TOMOYA SUDOU, FUMIHIKO FUJITA, TAKEFUMI YOSHIDA, KENICHI KOUSHI, TAKASHI NOGUCHI, JUNYA FUKUDA, NANAE OGATA, YOSHITAKA NOBUKUNI and YOSHITO AKAGI

Anticancer Research August 2022, 42 (8) 4011-4016; DOI: https://doi.org/10.21873/anticanres.15897
You have access
Molecular Interaction Between Boron Tracedrug UTX-51 Derivatives and Bovine Serum Albumin: Application to an Analytical Model of AGEs Destruction by Thermal Neutron Irradiation
KAZUTO OHKURA, ATSUSHI TABATA, YOSHIHIRO UTO and HITOSHI HORI

Anticancer Research August 2022, 42 (8) 4017-4023; DOI: https://doi.org/10.21873/anticanres.15898
You have access
Effect of Chloroquine on Doxorubicin-induced Apoptosis in A549 Cells
KEISUKE SATO, NATSUKI OTA, SHOYA ENDO, AKIFUMI NAKATA, HIROSHI YAMASHITA and RYOSUKE TATSUNAMI

Anticancer Research August 2022, 42 (8) 4025-4035; DOI: https://doi.org/10.21873/anticanres.15899
You have access
Effect of Aspirin on G₀/G₁ Cell Cycle Arrest and microRNA Signatures in Pancreatic Adenocarcinoma Cells
RYOTA NAKABAYASHI, SHINTARO FUJIHARA, HISAKAZU IWAMA, SAE HAMAYA, TAKAAKI MIZUO, MASAHIRO HIRATA, KOJI FUJITA, TOSHIAKI KONO, DAISUKE NAMIMA, NAOKI FUJITA, HIROKI YAMANA, KIYOYUKI KOBAYASHI, HIDEKI KAMADA, ASAHIRO MORISHITA, HIDEKI KOBARA, MASAFUMI ONO, KEIICHI OKANO and TSUTOMU MASAKI

Anticancer Research August 2022, 42 (8) 4037-4048; DOI: https://doi.org/10.21873/anticanres.15900
You have access
Suppression of Inflammatory Cytokine Genes Expression in Vascular Endothelial Cells by Super-low Dose Lipopolysaccharide-activated Macrophages
TERUKO HONDA and HIROYUKI INAGAWA

Anticancer Research August 2022, 42 (8) 4049-4054; DOI: https://doi.org/10.21873/anticanres.15901
You have access
Oral Administration of Mulberry (Morus alba L.) Leaf Powder Prevents the Development of Hepatocellular Carcinoma in Stelic Animal Model (STAM) Mice
KOJI WAKAME, KEISUKE SATO, MASAFUMI KASAI, EMI KIKUCHI, KIHIRO SHIMIZU, AKO KUDO, KEN-ICHI KOMATSU and AKIFUMI NAKATA

Anticancer Research August 2022, 42 (8) 4055-4062; DOI: https://doi.org/10.21873/anticanres.15902

Clinical Studies

Open Access
Salvage PTBD With Chemotherapy Improves Survival in Patients With Unresectable Malignant Biliary Obstruction – A Single Center Retrospective Study
DAISUKE MUROYA, HIROTOSHI TSURU, HISAAKI SHIMOKOBE, YUICHI NAGAO, YASUNORI YOSHIMOTO, YOSHITO WADA, KOUJI HAYASHI, SATOSHI TANIWAKI, RYUTA MIDORIKAWA, SHINICHI TANIWAKI, SATOKI KOJIMA, SHOICHIRO ARAI, TAKAHISA SHIRAHAMA, YUICHI GOTO, HISAMUNE SAKAI, MUNEHIRO YOSHITOMI, TORU HISAKA, YOSHITO AKAGI and KOJI OKUDA

Anticancer Research August 2022, 42 (8) 4063-4070; DOI: https://doi.org/10.21873/anticanres.15903
Open Access
CCND1 Copy Number Variation in Circulating Tumor DNA from Luminal B Breast Cancer Patients
AKIKO SHIMAZAKI, MAKOTO KUBO, KANAKO KURATA, YUKA TAKAO, SAORI HAYASHI, YURINA HARADA, HITOMI KAWAJI, KAZUHISA KANESHIRO, MAI YAMADA, MASAYA KAI and MASAFUMI NAKAMURA

Anticancer Research August 2022, 42 (8) 4071-4077; DOI: https://doi.org/10.21873/anticanres.15904
Open Access
Tumour Budding as an Independent Prognostic Factor for Survival in Patients With Distal Bile Duct Cancer
GOICHI NAKAYAMA, TORU HISAKA, HISAMUNE SAKAI, MASANORI AKASHI, GOTO YUICHI, TOSHIHIRO SATO, YOSHIKI NAITO, JUN AKIBA, HIROHISA YANO and YOSHITO AKAGI

Anticancer Research August 2022, 42 (8) 4079-4087; DOI: https://doi.org/10.21873/anticanres.15905
Open Access
Liberal Application of Portal Vein Embolization for Right Hepatectomy Against Hepatocellular Carcinoma: Strategy to Achieve Zero Mortality for a Damaged Liver
NOBUHISA SHIRAHAMA, YUICHI GOTO, HISAMUNE SAKAI, SHOGO FUKUTOMI, MASANORI AKASHI, TOSHIHIRO SATO, YOSHITO AKAGI, KOJI OKUDA and TORU HISAKA

Anticancer Research August 2022, 42 (8) 4089-4095; DOI: https://doi.org/10.21873/anticanres.15906
Open Access
Significance of the Multi-gene Panel myRisk in Japan
SAORI HAYASHI, MAKOTO KUBO, SAWAKO MATSUZAKI, MASAYA KAI, TAKAFUMI MORISAKI, MAI YAMADA, KAZUHISA KANESHIRO, YUKA TAKAO, AKIKO SHIMAZAKI, KINUKO NAGAYOSHI, YUSUKE MIZUUCHI and MASAFUMI NAKAMURA

Anticancer Research August 2022, 42 (8) 4097-4102; DOI: https://doi.org/10.21873/anticanres.15907
Open Access
Standardized Methods Using EUS-guided Fine-needle Biopsy and a Minimal Medium Creates Three Pancreatic Cancer Organoids
YUSUKE ISHIDA, TOSHIYUKI TSUNODA, YOSHIHIRO HAMADA, NAOAKI TSUCHIYA, TAKEHIKO KOGA, TAKANORI KITAGUCHI, KEISUKE MATSUMOTO, SHINJI MATSUMOTO, TAKAHIDE SASAKI, RYO NAKASHIMA, FUMINORI ISHII, MASATOSHI KAJIWARA, SENJI SHIRASAWA, SUGURU HASEGAWA and FUMIHITO HIRAI

Anticancer Research August 2022, 42 (8) 4103-4109; DOI: https://doi.org/10.21873/anticanres.15908
You have access
Cumulative Summation Analysis of Learning Curve for Robotic-assisted Hysterectomy in Patients With Gynecologic Tumors
FUSANORI YOTSUMOTO, AYAKO SANUI, TOMOHIRO ITO, DAISUKE MIYAHARA, KENICHI YOSHIKAWA, KOICHIRO SHIGEKAWA, YUKIKO NOGUCHI, SHIN’ICHIRO YASUNAGA and SHINGO MIYAMOTO

Anticancer Research August 2022, 42 (8) 4111-4117; DOI: https://doi.org/10.21873/anticanres.15909
Open Access
Chitinase 3-like 1, Carcinoembryonic Antigen-related Cell Adhesion Molecule 6, and Ectopic Claudin-2 in the Carcinogenic Processes of Ulcerative Colitis
TETSUSHI KINUGASA, TOSHIYUKI TSUNODA, EMIKO MIZOGUCHI, TOSHIYUKI OKADA, TOMOYA SUDO, AKIHIKO KAWAHARA, JUN AKIBA and YOSHITO AKAGI

Anticancer Research August 2022, 42 (8) 4119-4127; DOI: https://doi.org/10.21873/anticanres.15910
Open Access
Hematogenous Dissemination of Tumor Cells in Hepatocellular Carcinoma: Comparing Anterior and Non-anterior Approach Hepatectomy
SHIN SASAKI, YORIKO NOMURA, TOMOYA SUDO, HISAMUNE SAKAI, TORU HISAKA, JUN AKIBA, OSAMU NAKASHIMA, HIROHISA YANO, MASAYOSHI KAGE, YOSHITO AKAGI and KOJI OKUDA

Anticancer Research August 2022, 42 (8) 4129-4137; DOI: https://doi.org/10.21873/anticanres.15911
You have access
Efficacy and Safety of Monthly Minodronate Therapy in Postmenopausal Breast Cancer Patients Receiving Aromatase Inhibitors
NANAE OGATA, UHI TOH, TOMOYA SUDOU, SUGURU OGATA, YUKO TAKAO, RIE SUGIHARA, HIDEAKI WATANABE, SHUNTARO MATUSHIMA and YOSHITO AKAGI

Anticancer Research August 2022, 42 (8) 4139-4143; DOI: https://doi.org/10.21873/anticanres.15912
You have access
Predictive and Prognostic Value of SUOX Expression in Pancreatic Ductal Adenocarcinoma
YOSHIKI NAITO, JUN AKIBA, YOSHINAO KINJO, EIJI SADASHIMA, TOSHIRO OGATA, YUTA YANO, MASAHIKO TANIGAWA, MASAMICHI NAKAYAMA, AKIHIKO KAWAHARA, YOSHINOBU OKABE, HISAMUNE SAKAI, TORU HISAKA, YOSHITO AKAGI and HIROHISA YANO

Anticancer Research August 2022, 42 (8) 4145-4151; DOI: https://doi.org/10.21873/anticanres.15913
You have access
Pancreaticoenterostomy With Seromuscular-parenchymal Anastomosis for Prevention of Postoperative Pancreatic Fistula in Distal Pancreatectomy
SATOSHI TANIWAKI, DAISUKE MUROYA, YOSHITO WADA, KOUJI OKUDA, HIROTOSHI TSURU, HISAAKI SHIMOKOUBE, YUICH NAGAO, KOUJI HAYASHI and YUKI YOSHIMOTO

Anticancer Research August 2022, 42 (8) 4153-4157; DOI: https://doi.org/10.21873/anticanres.15914
You have access
Fatty Liver Does Not Increase the Risk of Postoperative Liver Damage Following Hepatectomy
YORIKO NOMURA, JUN AKIBA, HIROHISA YANO, YOSHITO AKAGI and TORU HISAKA

Anticancer Research August 2022, 42 (8) 4159-4164; DOI: https://doi.org/10.21873/anticanres.15915
You have access
Adverse Events Associated With Long-term Treatment of Epithelial Ovarian Cancer With Bevacizumab and Chemotherapy
YUKA YOKOYAMA, MICHIKO KUBO-KANEDA, KIMI SUNADA, YASUHIRO TEISHIKATA, ASA KITAMURA, KOTA OKAMOTO, KUNIAKI TORIYABE, MASAFUMI NII, KENTA YOSHIDA, EIJI KONDO and TOMOAKI IKEDA

Anticancer Research August 2022, 42 (8) 4165-4171; DOI: https://doi.org/10.21873/anticanres.15916
You have access
Experience With Tirabrutinib in the Treatment of Primary Central Nervous System Lymphoma that Is Difficult to Treat With Standard Treatment
HIROMASA YOSHIOKA, TAKESHI OKUDA, TAKAYUKI NAKAO, MITSUGU FUJITA and JUN C. TAKAHASHI

Anticancer Research August 2022, 42 (8) 4173-4178; DOI: https://doi.org/10.21873/anticanres.15917
You have access
Efficacy of Adjuvant Immune-cell Therapy Combined With Systemic Therapy for Solid Tumors
RISHU TAKIMOTO, TAKASHI KAMIGAKI, SACHIKO OKADA, HIROSHI IBE, ERI OGUMA and SHIGENORI GOTO

Anticancer Research August 2022, 42 (8) 4179-4187; DOI: https://doi.org/10.21873/anticanres.15918

Main menu

User menu

Search

Table of Contents

Review

Experimental Studies

Clinical Studies

PROCEEDINGS OF THE 25TH ANNUAL MEETING OF THE SOCIETY OF BIOTHERAPEUTIC APPROACHES

Preface

Experimental Studies

Clinical Studies

In this issue

Issue highlights

Jump to